ABL Bio (Korea) Top Management
| 298380 Stock | KRW 25,500 300.00 1.16% |
ABL Bio employs about 7 people. The company is managed by 7 executives with a total tenure of roughly 17 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Analysis of ABL Bio's management performance can provide insight into the company performance.
| Jung Kim Insider MD COO |
| Jaecheon Lee Insider MD CFO |
ABL |
ABL Bio Management Team Effectiveness
The company has return on total asset (ROA) of (0.3051) % which means that it has lost $0.3051 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 5.5983 %, meaning that it generated $5.5983 on every $100 dollars invested by stockholders. ABL Bio's management efficiency ratios could be used to measure how well ABL Bio manages its routine affairs as well as how well it operates its assets and liabilities.ABL Bio Workforce Comparison
ABL Bio is number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is presently estimated at about 130. ABL Bio holds roughly 7.0 in number of employees claiming about 5% of stocks in Biotechnology industry.
ABL Bio Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. ABL Bio Price Series Summation is a cross summation of ABL Bio price series and its benchmark/peer.
ABL Bio Notable Stakeholders
An ABL Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ABL Bio often face trade-offs trying to please all of them. ABL Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ABL Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jung Kim | MD COO | Profile | |
| Jaecheon Lee | MD CFO | Profile | |
| Jae Jung | MD Discovery | Profile | |
| Jong Kim | MD Devel | Profile | |
| Sang Lee | Founder CEO | Profile | |
| You WeonKyoo | Head MD | Profile | |
| Jong Won | Head Devel | Profile |
About ABL Bio Management Performance
The success or failure of an entity such as ABL Bio often depends on how effective the management is. ABL Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ABL management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ABL management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.
The data published in ABL Bio's official financial statements usually reflect ABL Bio's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ABL Bio. For example, before you start analyzing numbers published by ABL accountants, it's critical to develop an understanding of what ABL Bio's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of ABL Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABL Bio's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ABL Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ABL Bio. Please utilize our Beneish M Score to check the likelihood of ABL Bio's management manipulating its earnings.
ABL Bio Workforce Analysis
Traditionally, organizations such as ABL Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ABL Bio within its industry.ABL Bio Manpower Efficiency
Return on ABL Bio Manpower
| Revenue Per Employee | 761.7M | |
| Revenue Per Executive | 761.7M | |
| Net Loss Per Employee | 6.2B | |
| Net Loss Per Executive | 6.2B |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABL Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the ABL Bio information on this page should be used as a complementary analysis to other ABL Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for ABL Stock analysis
When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |